Literature DB >> 22417893

The role of cell-extracellular matrix interactions in glomerular injury.

Corina M Borza1, Ambra Pozzi.   

Abstract

Glomerulosclerosis is characterized by excessive deposition of extracellular matrix within the glomeruli of the kidney, glomerular cell death, and subsequent loss of functional glomeruli. While in physiological situations the levels of extracellular matrix components are kept constant by a tight balance between formation and degradation, in the case of injury that results in fibrosis there is increased matrix deposition relative to its breakdown. Multiple factors control matrix synthesis and degradation, thus contributing to the development of glomerulosclerosis. This review focuses primarily on the role of cell-matrix interactions, which play a critical role in governing glomerular cell cues in both healthy and diseased kidneys. Cell-extracellular matrix interactions are made possible by various cellular receptors including integrins, discoidin domain receptors, and dystroglycan. Upon binding to a selective extracellular matrix protein, these receptors activate intracellular signaling pathways that can either downregulate or upregulate matrix synthesis and deposition. This, together with the observation that changes in the expression levels of matrix receptors have been documented in glomerular disease, clearly emphasizes the contribution of cell-matrix interactions in glomerular injury. Understanding the molecular mechanisms whereby extracellular matrix receptors regulate matrix homeostasis in the course of glomerular injury is therefore critical for devising more effective therapies to treat and ideally prevent glomerulosclerosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417893      PMCID: PMC3770307          DOI: 10.1016/j.yexcr.2012.02.033

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  98 in total

1.  The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.

Authors:  Birgit Leitinger; Andrzej Steplewski; Andrzej Fertala
Journal:  J Mol Biol       Date:  2004-12-03       Impact factor: 5.469

2.  Expression of beta 1-integrins on activated mesangial cells in human glomerulonephritis.

Authors:  T Kuhara; S Kagami; Y Kuroda
Journal:  J Am Soc Nephrol       Date:  1997-11       Impact factor: 10.121

3.  Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.

Authors:  Oliver Gross; Rainer Girgert; Bogdan Beirowski; Matthias Kretzler; Hee Gyung Kang; Jenny Kruegel; Nicolai Miosge; Ann-Christin Busse; Stephan Segerer; Wolfgang F Vogel; Gerhard-Anton Müller; Manfred Weber
Journal:  Matrix Biol       Date:  2010-03-20       Impact factor: 11.583

4.  Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.

Authors:  Andrea Hartner; Nada Cordasic; Carlos Menendez-Castro; Gudrun Volkert; Julie M Yabu; Miroslava Kupraszewicz-Hutzler; Wolfgang Rascher; Karl F Hilgers
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-08

5.  Glomerular and renal vascular structural changes in alpha8 integrin-deficient mice.

Authors:  Christian S Haas; Kerstin Amann; Johannes Schittny; Barbara Blaser; Ulrich Müller; Andrea Hartner
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

6.  Expression of sialidase and dystroglycan in human glomerular diseases.

Authors:  Nils P J Vogtländer; Johan van der Vlag; Marinka A H Bakker; Henry B Dijkman; Ron A Wevers; Kevin P Campbell; Jack F M Wetzels; Jo H M Berden
Journal:  Nephrol Dial Transplant       Date:  2009-09-15       Impact factor: 5.992

7.  Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.

Authors:  Martin Zenker; Thomas Aigner; Olaf Wendler; Tim Tralau; Horst Müntefering; Regina Fenski; Susanne Pitz; Valérie Schumacher; Brigitte Royer-Pokora; Elke Wühl; Pierre Cochat; Raymonde Bouvier; Cornelia Kraus; Karlheinz Mark; Henry Madlon; Jörg Dötsch; Wolfgang Rascher; Iwona Maruniak-Chudek; Thomas Lennert; Luitgard M Neumann; André Reis
Journal:  Hum Mol Genet       Date:  2004-09-14       Impact factor: 6.150

8.  Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity.

Authors:  Ambra Pozzi; George Jarad; Gilbert W Moeckel; Sergio Coffa; Xi Zhang; Leslie Gewin; Vera Eremina; Billy G Hudson; Dorin-Bogdan Borza; Raymond C Harris; Lawrence B Holzman; Carrie L Phillips; Reinhard Fassler; Susan E Quaggin; Jeffrey H Miner; Roy Zent
Journal:  Dev Biol       Date:  2008-01-31       Impact factor: 3.582

9.  Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.

Authors:  Keizo Kanasaki; Yoshiko Kanda; Kristin Palmsten; Harikrishna Tanjore; Soo Bong Lee; Valerie S Lebleu; Vincent H Gattone; Raghu Kalluri
Journal:  Dev Biol       Date:  2007-11-12       Impact factor: 3.582

10.  Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.

Authors:  Huifang Xu; Nicolas Raynal; Stavros Stathopoulos; Johanna Myllyharju; Richard W Farndale; Birgit Leitinger
Journal:  Matrix Biol       Date:  2010-10-28       Impact factor: 11.583

View more
  12 in total

1.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

2.  Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruli.

Authors:  Liliane Hobeika; Michelle T Barati; Dawn J Caster; Kenneth R McLeish; Michael L Merchant
Journal:  Kidney Int       Date:  2016-12-15       Impact factor: 10.612

3.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  The Role of the EGF Receptor in Sex Differences in Kidney Injury.

Authors:  Ming-Zhi Zhang; Kensuke Sasaki; Yan Li; Zhilian Li; Yu Pan; Guan-Nan Jin; Yinqiu Wang; Aolei Niu; Suwan Wang; Xiaofeng Fan; Jian Chun Chen; Corina Borza; Haichun Yang; Ambra Pozzi; Agnes B Fogo; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2019-07-10       Impact factor: 10.121

5.  Graphene-Based Materials for Efficient Neurogenesis.

Authors:  Yeon-Woo Cho; Kwang-Ho Lee; Tae-Hyung Kim
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 6.  Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View.

Authors:  Corina M Borza; Xiwu Chen; Roy Zent; Ambra Pozzi
Journal:  Curr Top Membr       Date:  2015       Impact factor: 3.049

7.  A different perspective on the filtration barrier after kidney stone formation: An immunohistochemical and biochemical study.

Authors:  Derya Karabulut; Emin Kaymak; Betül Yalçin; Harun Ulger; Didem Barlak Keti
Journal:  Urolithiasis       Date:  2020-11-05       Impact factor: 3.436

Review 8.  Integrins in kidney disease.

Authors:  Ambra Pozzi; Roy Zent
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

9.  p47(phox) contributes to albuminuria and kidney fibrosis in mice.

Authors:  Hongtao Wang; Xiwu Chen; Yan Su; Paisit Paueksakon; Wen Hu; Ming-Zhi Zhang; Raymond C Harris; Timothy S Blackwell; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2015-01-07       Impact factor: 10.612

10.  Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.

Authors:  Chin-Wei Chiang; Hsueh-Te Lee; Der-Cherng Tarng; Ko-Lin Kuo; Li-Ching Cheng; Tzong-Shyuan Lee
Journal:  Mediators Inflamm       Date:  2015-01-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.